Jiong Zhao to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Jiong Zhao has written about Xenograft Model Antitumor Assays.
Connection Strength
0.102
-
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Proc Natl Acad Sci U S A. 2022 01 25; 119(4).
Score: 0.040
-
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. J Med Chem. 2020 07 09; 63(13):7186-7210.
Score: 0.036
-
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer. J Med Chem. 2016 Jan 14; 59(1):219-237.
Score: 0.026